New fat cell metabolism research could lead to new ways to treat diabetes and obesity

November 16, 2015

Researchers at the University of California, San Diego report new insights into what nutrients fat cells metabolize to make fatty acids. The findings pave the way for understanding potential irregularities in fat cell metabolism that occur in patients with diabetes and obesity and could lead to new treatments for these conditions. The researchers published their findings online in the Nov. 16 issue of Nature Chemical Biology.

"This study highlights how specific tissues in our bodies use particular nutrients. By understanding fat cell metabolism at the molecular level, we are laying the groundwork for further research to identify better drug targets for treating diabetes and obesity," said Christian Metallo, a bioengineering professor in the Jacobs School of Engineering at UC San Diego and senior author of the study. Metallo is affiliated with the Institute for Engineering in Medicine, the Moore's Cancer Center, and the CHO Systems Biology Center, all at UC San Diego.

In the new study, researchers discovered that as fat cells develop, they change what types of nutrients they metabolize to produce fat and energy. Pre-adipocytes, which are precursors to fat cells, preferentially consume glucose, a simple sugar, to grow and make energy. But when pre-adipocytes become fat cells, researchers found that they metabolize not just glucose, but also branched-chain amino acids, a small set of the essential amino acids for humans.

This finding is important because it shows that fat cells play an important role in regulating the body's levels of branched-chain amino acids -- which are typically elevated in individuals with diabetes and obesity.

"We've taken a step towards understanding why these amino acids are accumulating in the blood of diabetics and those suffering from obesity," said Courtney Green, a bioengineering Ph.D. student at UC San Diego and first author of the study. "The next step is to understand how and why this metabolic pathway becomes impaired in the fat cells of these individuals."

Metallo and his team studied the metabolism of fat cells from the pre-adipocyte stage throughout the fat cell differentiation process. They induced pre-adipocytes to differentiate into fat cells and cultured the cells in media containing nutrients enriched with carbon-13 isotopes, a form of carbon atoms that are used as metabolic tracers in cells, animals, and people. Through this method, researchers were able to trace what carbon-based nutrients the cells metabolized and what they produced at different stages of the cell differentiation process.

"We are curious about how different cells in our body, such as fat cells, consume and metabolize their surrounding nutrients. A better understanding of how these biochemical pathways are used by cells could help us find new approaches to treat diseases such as cancer or diabetes," said Metallo.
-end-
This work was supported by the National Institutes of Health, the California Institute of Regenerative Medicine, the US Department of Defense, a Searle Scholar Award, and grants from the American Diabetes Association, the Medical Research Service, the US Department of Veterans Affairs and the VA San Diego Healthcare System, and Seahorse Bioscience.

Full paper: "Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis" by Courtney R. Green, Martina Wallace, Ajit S. Divakaruni, Susan A. Philips, Anne M. Murphy, Theodore P. Ciaraldi, and Christian M. Metallo. The paper was published online in the Nov. 16, 2015 issue of the journal Nature Chemical Biology.

University of California - San Diego

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.